<DOC>
	<DOCNO>NCT01118312</DOCNO>
	<brief_summary>The trial study effectiveness nasal steroid treatment chronic rhinitis and/or sinusitis asthma control .</brief_summary>
	<brief_title>Study Asthma Nasal Steroids</brief_title>
	<detailed_description>Previous trial complete American Lung Association-Airways Clinical Research Centers ( ALA-ACRC ) network identify rhinitis and/or sinusitis significant co-morbidity people asthma affect asthma symptom control . The objective clinical trial determine treatment chronic rhinitis and/or sinusitis nasal steroid improves control asthma child adult . Although chronic rhinitis and/or sinusitis associate poor asthma control increase health care utilization , effect treat disease asthma control know . This six-month randomized , double-blinded , placebo-controlled trial enrol 380 participant , 190 child 190 adult , poorly control asthma chronic rhinitis/sinusitis . Participants randomize receive nasal steroid match placebo addition regular asthma treatment . The primary objective trial evaluate whether addition treatment nasal steroid improve asthma control . We perform allergy skin test participant keep record pollen count center , determine allergy important factor response nasal steroid participant .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Sinusitis</mesh_term>
	<mesh_term>Mometasone Furoate</mesh_term>
	<criteria>Physician diagnose asthma At least 12 % increase force expiratory volume one second ( FEV1 ) 24 puff albuterol positive methacholine challenge ( 20 % fall FEV1 le 16 mg/ml methacholine ) ; either available last 2 year enrollment Poorly control asthma document score 19 less Asthma Control Test ( ACT ) participants 12 older , Childhood Asthma Control Test ( CACT ) 611 year ( V1 V2 ) . Chronic symptom rhinitis sinusitis measure mean score 1 Sinonasal questionnaire Males female , age 6 old Comorbidity predisposes complicate rhinosinusitis ( e.g. , cystic fibrosis , insulin dependent diabetes mellitus , immunodeficiency disorder ) Chronic disease ( asthma ) opinion investigator would prevent participation trial put participant risk participation , e.g . chronic disease lung ( asthma ) , heart , liver , kidney nervous system . History sinus surgery last 6 month Systemic/nasal steroid within last 4 week Antileukotriene medication History upper airway symptom less 8 week time enrollment Fever &gt; 38.3 degree Celsius patient history fever last 10 day Greater 10 pack year smoke history active smoking within last 6 month FEV1 &lt; 50 % predict Females childbearing potential pregnant lactating , unwilling practice adequate birth control method Allergy intolerance nasal mometasone Cataracts , history glaucoma , condition result increased intraocular pressure Any investigational drug last 6 week Inability comply study procedure , include : Inability unwillingness provide inform consent ( assent case minor ) Inability take study medication Inability perform baseline measurement Completion less 10 14 day screen period diary entry Inability contact phone Intention move area within 6 month</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Rhinitis</keyword>
	<keyword>Sinusitis</keyword>
	<keyword>Chronic</keyword>
	<keyword>ACRC</keyword>
	<keyword>STAN</keyword>
	<keyword>Nasal steroid</keyword>
	<keyword>Mometasone</keyword>
	<keyword>Nasal spray</keyword>
</DOC>